Ferumoxytol is an intravenous iron replacement agent, classified as a superparamagnetic iron oxide nanoparticle coated with a carbohydrate shell, indicated for the treatment of iron deficiency anemia in… Read more
Ferumoxytol is an intravenous iron replacement agent, classified as a superparamagnetic iron oxide nanoparticle coated with a carbohydrate shell, indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease or those who cannot tolerate oral iron supplementation. This category provides essential materials for pharmaceutical laboratories engaged in the analytical testing, method validation, and quality control of this therapeutic formulation. Included are high-quality reference standards of Ferumoxytol, alongside its specific organic impurities, potential metabolites, and stable isotope-labelled compounds. These reference materials are critical for accurate impurity profiling and for developing robust quantification methods, such as ion chromatography or mass spectrometry, ensuring the safety, stability, and therapeutic integrity of the drug product throughout its manufacturing and lifecycle.